Vermont’s law restricting the sale of prescription drug information that identifies prescribers and patients for commercial marketing purposes does not restrict free speech and serves substantial governmental interests, according to a brief to be filed today by an American University Washington College of Law professor on behalf of AARP and organizations representing physicians, state legislatures, consumers, and public policy advocates.
Press Release – Media Newswire